Literature DB >> 25216320

Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations.

Alberto Cavazza1, Francesco Muratore, Luigi Boiardi, Giovanna Restuccia, Nicolò Pipitone, Giulia Pazzola, Elena Tagliavini, Moira Ragazzi, Giulio Rossi, Carlo Salvarani.   

Abstract

We reviewed 888 temporal artery biopsies (TAB) performed in 871 patients in a single institution from January 1986 to December 2013. Forty-four biopsies (4.9%) were inadequate, 490 (55.2%) were devoid of inflammation and were considered negative, and 354 (39.9%) showed inflammation and were considered positive. On the basis of the localization of the inflammation, positive TABs were further classified into 4 categories: small vessel vasculitis (SVV), in which inflammation was limited to small periadventitial vessels devoid of muscular coat, with sparing of the temporal artery (32 cases, 9% of the positive biopsies); vasa vasorum vasculitis (VVV), in which inflammation was limited to the adventitial vasa vasorum (23 cases, 6.5% of the positive biopsies); inflammation limited to adventitia (ILA), in which inflammation extended from a strictly perivascular localization to the surrounding adventitia, without medial involvement (25 cases, 7% of the positive biopsies); and transmural inflammation (TMI), in which inflammation crossed the external elastic lamina and extended to the media (274 cases, 77.5% of the positive biopsies). In TMI, inflammation was generally more prominent between media and adventitia and mostly consisted of T lymphocytes and macrophages, with occasionally a significant number of plasma cells. Numerous eosinophils or neutrophils (with or without leucocytoclasia and suppurative necrosis), fibrinoid necrosis (limited to small branches of the temporal artery), and acute thrombosis were unusual, being present in 8%, 1.8%, 0.7%, and 9.5% of our biopsies with TMI, respectively. Giant cells, laminar necrosis, and calcifications prevailed along the internal elastic lamina and were present in 74.8%, 25.2%, and 20% of the biopsies with TMI, respectively. Among the 322 patients with positive TAB on whom we obtained clinical information, 317 had giant cell arteritis and 5 had a different disease: 3 (with SVV at histology) had ANCA-associated vasculitis, 1 (with SVV with amyloid deposits) had primary systemic amyloidosis, and 1 (with TMI limited to a small branch) had polyarteritis nodosa. In none of these cases the biopsy showed fibrinoid necrosis or significant numbers of eosinophils or neutrophils. Considering the 317 patients with giant cell arteritis, those with SVV and VVV compared with those with TMI had a significantly lower frequency of cranial manifestation (including headache, jaw claudication, and abnormalities of temporal arteries), lower serum levels of acute-phase reactants, and a reduced frequency of prednisone therapy at the time of TAB, of the "halo sign" at color duplex sonography of temporal arteries, and of systemic symptoms (for VVV). Polymyalgia rheumatica and blindness were equally represented in all patients groups, whereas there was a higher frequency of male sex and peripheral arthritis in patients with SVV. Patients with ILA were more similar to those with TMI, having a lower frequency of headache, of abnormalities of temporal arteries, and of a positive "halo sign" at color duplex sonography of temporal arteries. In conclusion, the histologic spectrum of inflammatory lesions that can be found in TAB is broad, and the differences have clinical implications.

Entities:  

Mesh:

Year:  2014        PMID: 25216320     DOI: 10.1097/PAS.0000000000000244

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

Review 1.  Inflammatory and infectious aortic diseases.

Authors:  Amy R Deipolyi; Christopher D Czaplicki; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

2.  The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study.

Authors:  Christian Löffler; Johannes Hoffend; Urs Benck; Bernhard K Krämer; Raoul Bergner
Journal:  Clin Rheumatol       Date:  2017-05-15       Impact factor: 2.980

Review 3.  Giant cell arteritis and polymyalgia rheumatica: an update.

Authors:  Miguel A González-Gay; Trinitario Pina
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

4.  Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort.

Authors:  Thomas D Garvey; Matthew J Koster; Cynthia S Crowson; Kenneth J Warrington
Journal:  Semin Arthritis Rheum       Date:  2021-09-27       Impact factor: 5.532

5.  Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.

Authors:  Gil Bornstein; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Nadav Furie; Chagai Grossman
Journal:  Clin Rheumatol       Date:  2018-03-17       Impact factor: 2.980

Review 6.  Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.

Authors:  Ryu Watanabe; Ebru Hosgur; Hui Zhang; Zhenke Wen; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Joint Bone Spine       Date:  2016-09-20       Impact factor: 4.929

7.  Arteritic Anterior Ischaemic Optic Neuropathy with Unusual Systemic Manifestations.

Authors:  Masoud Aghsaei Fard; Zohreh Nozarian; Amirreza Veisi
Journal:  Neuroophthalmology       Date:  2019-08-19

8.  Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.

Authors:  Ryu Watanabe; Jörg J Goronzy; Gerald Berry; Y Joyce Liao; Cornelia M Weyand
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-04-11

9.  Response to 'interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain'.

Authors:  Peter A Simkin
Journal:  Arthritis Res Ther       Date:  2015-04-28       Impact factor: 5.156

10.  Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis.

Authors:  José Hernández-Rodríguez; Giuseppe Murgia; Irama Villar; Elías Campo; Sarah L Mackie; Aruna Chakrabarty; Elizabeth M A Hensor; Ann W Morgan; Carme Font; Sergio Prieto-González; Georgina Espígol-Frigolé; Josep M Grau; Maria C Cid
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.